BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 31837737)

  • 1. Streamlined production of genetically modified T cells with activation, transduction and expansion in closed-system G-Rex bioreactors.
    Gagliardi C; Khalil M; Foster AE
    Cytotherapy; 2019 Dec; 21(12):1246-1257. PubMed ID: 31837737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of Retronectin-Mediated T-Cell Activation on Expansion and Phenotype of CD19-Specific Chimeric Antigen Receptor T Cells.
    Stock S; Hoffmann JM; Schubert ML; Wang L; Wang S; Gong W; Neuber B; Gern U; Schmitt A; Müller-Tidow C; Dreger P; Schmitt M; Sellner L
    Hum Gene Ther; 2018 Oct; 29(10):1167-1182. PubMed ID: 30024314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simplified process for the production of anti-CD19-CAR-engineered T cells.
    Tumaini B; Lee DW; Lin T; Castiello L; Stroncek DF; Mackall C; Wayne A; Sabatino M
    Cytotherapy; 2013 Nov; 15(11):1406-15. PubMed ID: 23992830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Large-scale expansion of Vγ9Vδ2 T cells with engineered K562 feeder cells in G-Rex vessels and their use as chimeric antigen receptor-modified effector cells.
    Xiao L; Chen C; Li Z; Zhu S; Tay JC; Zhang X; Zha S; Zeng J; Tan WK; Liu X; Chng WJ; Wang S
    Cytotherapy; 2018 Mar; 20(3):420-435. PubMed ID: 29402645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different cytokine and stimulation conditions influence the expansion and immune phenotype of third-generation chimeric antigen receptor T cells specific for tumor antigen GD2.
    Gargett T; Brown MP
    Cytotherapy; 2015 Apr; 17(4):487-95. PubMed ID: 25573334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methods and Process Optimization for Large-Scale CAR T Expansion Using the G-Rex Cell Culture Platform.
    Ludwig J; Hirschel M
    Methods Mol Biol; 2020; 2086():165-177. PubMed ID: 31707675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A quality-by-design approach to improve process understanding and optimise the production and quality of CAR-T cells in automated stirred-tank bioreactors.
    Hood T; Slingsby F; Sandner V; Geis W; Schmidberger T; Bevan N; Vicard Q; Hengst J; Springuel P; Dianat N; Rafiq QA
    Front Immunol; 2024; 15():1335932. PubMed ID: 38655265
    [No Abstract]   [Full Text] [Related]  

  • 8. Large-scale expansion of cytomegalovirus-specific cytotoxic T cells in suspension culture.
    Foster AE; Forrester K; Gottlieb DJ; Barton GW; Romagnoli JA; Bradstock KF
    Biotechnol Bioeng; 2004 Jan; 85(2):138-46. PubMed ID: 14704996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retronectin-assisted retroviral transduction of primary human T lymphocytes under good manufacturing practice conditions: tissue culture bag critically determines cell yield.
    Lamers CH; van Elzakker P; van Steenbergen SC; Sleijfer S; Debets R; Gratama JW
    Cytotherapy; 2008; 10(4):406-16. PubMed ID: 18574773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization of lentiviral vector transduction into peripheral blood mononuclear cells in combination with the fibronectin fragment CH-296 stimulation.
    Chono H; Goto Y; Yamakawa S; Tanaka S; Tosaka Y; Nukaya I; Mineno J
    J Biochem; 2011 Mar; 149(3):285-92. PubMed ID: 21106541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protocol for gene transduction and expansion of human T lymphocytes for clinical immunogene therapy of cancer.
    Lamers CH; Willemsen RA; Luider BA; Debets R; Bolhuis RL
    Cancer Gene Ther; 2002 Jul; 9(7):613-23. PubMed ID: 12082462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new approach to CAR T-cell gene engineering and cultivation using piggyBac transposon in the presence of IL-4, IL-7 and IL-21.
    Ptáčková P; Musil J; Štach M; Lesný P; Němečková Š; Král V; Fábry M; Otáhal P
    Cytotherapy; 2018 Apr; 20(4):507-520. PubMed ID: 29475789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of Human NK Cell Manufacturing: Fully Automated Separation, Improved Ex Vivo Expansion Using IL-21 with Autologous Feeder Cells, and Generation of Anti-CD123-CAR-Expressing Effector Cells.
    Klöß S; Oberschmidt O; Morgan M; Dahlke J; Arseniev L; Huppert V; Granzin M; Gardlowski T; Matthies N; Soltenborn S; Schambach A; Koehl U
    Hum Gene Ther; 2017 Oct; 28(10):897-913. PubMed ID: 28810809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Closed-system manufacturing of CD19 and dual-targeted CD20/19 chimeric antigen receptor T cells using the CliniMACS Prodigy device at an academic medical center.
    Zhu F; Shah N; Xu H; Schneider D; Orentas R; Dropulic B; Hari P; Keever-Taylor CA
    Cytotherapy; 2018 Mar; 20(3):394-406. PubMed ID: 29287970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced clinical-scale manufacturing of TCR transduced T-cells using closed culture system modules.
    Jin J; Gkitsas N; Fellowes VS; Ren J; Feldman SA; Hinrichs CS; Stroncek DF; Highfill SL
    J Transl Med; 2018 Jan; 16(1):13. PubMed ID: 29368612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A closed-culture system using a GMP-grade culture bag and anti-CD3/28 coated bead stimulation for CD4
    Thitilertdecha P; Suwannachod P; Poungpairoj P; Tantithavorn V; Khowawisetsut L; Ammaranond P; Onlamoon N
    J Immunol Methods; 2018 Sep; 460():17-25. PubMed ID: 29894747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and Validation of a Good Manufacturing Process for IL-4-Driven Expansion of Chimeric Cytokine Receptor-Expressing CAR T-Cells.
    van Schalkwyk MCI; van der Stegen SJC; Bosshard-Carter L; Graves H; Papa S; Parente-Pereira AC; Farzaneh F; Fisher CD; Hope A; Adami A; Maher J
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-pass, closed-system rapid expansion of lymphocyte cultures for adoptive cell therapy.
    Klapper JA; Thomasian AA; Smith DM; Gorgas GC; Wunderlich JR; Smith FO; Hampson BS; Rosenberg SA; Dudley ME
    J Immunol Methods; 2009 Jun; 345(1-2):90-9. PubMed ID: 19389403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Closed loop bioreactor system for the ex vivo expansion of human T cells.
    Li M; Chin LY; Shukor S; Tamayo A; Maus MV; Parekkadan B
    Cytotherapy; 2019 Jan; 21(1):76-82. PubMed ID: 30497956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Large-scale expansion and characterization of CD3
    Coeshott C; Vang B; Jones M; Nankervis B
    J Transl Med; 2019 Aug; 17(1):258. PubMed ID: 31391068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.